FDA ApprovesFDA Authorization For COVID-19 Drug Combo

 

A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. (Photo by Sarah Silbiger/Getty Images)

The FDA granted an Emergency Use Authorization for a coronavirus drug combination to treat moderate and seriously ill patients.

FDA Commissioner Dr. Stephen M. Hahn said this action demonstrates the agency’s steadfast efforts to make potential coronavirus treatments available in a timely manner.

On Thursday, the FDA gave approval for the mix of ‘remdesevir’ and rheumatoid arthritis drug ‘baricitinib.’ This came after studies found the drug combination shortened the recovery time for COVID-19 to about a week.

According to a double-blind trial, the combination also increased the chances of survival by 35 percent when compared to patients that only took ‘remdesivir.’



Follow us on twitter (ajuede.com) or on Instagram (ajuedeman) for details of the global situation presently.

Comments

Popular posts from this blog

Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100% success

ORIGIN OF THE AKAN

GARDEN OF EDEN FOUND IN AFRICA

THE HISTORY AND ORIGIN OF THE ZULU PEOPLE

FIVE WAYS A WIFE CAN REST HER HUSBAND ON HER

BRIEF HISTORY OF NKALAHA.

MYSTERY OF IGBO COSMOLOGY

THE ORIGIN AND HISTORY OF UDI by Onyeji Nnaji

THE ORIGIN AND HISTORY OF NSUKKA by Onyeji Nnaji

ETHIOPIA:THE OLDEST PEOPLE IN THE MIDDLE EAST